Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1523 | Pituitary Clinical | ICEECE2012

GH deficiency after treatment of medulloblastoma and thyroid cancer: is this the case for GH therapy?

Valkusz Z. , Magony S. , Sepp K. , Csajbok E. , Julesz J. , Pavics L.

The hypothalamic–pituitary unit is a particularly radiosensitive region in the central nervous system. As a consequence, hypopituitarism commonly develops after radiation treatments for sellar and parasellar neoplasms, extrasellar brain tumours. Increasing tumour-related survival rates provide an expanding population at risk of developing hypopituitarism. The severity of hypopituitarism is related to the radiation doses given while whole body irradiation regimens to a dos...